Hestia Insight Inc. Subsidiary Enters Into Corporate Advisory Agreement With Aquiva Medical Inc.
LAS VEGAS, NV, March 21, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Hestia Insight Inc. (OTCQB:HSTA) (“Hestia Insight” and the “Company”), a company focused on the development and operation of novel technologies in the healthcare and biotech sectors, and providing marketing, management, business, and capital markets advisory services to its clients within the healthcare and biotech sectors, today announced that through its wholly owned subsidiary, Hestia Investments Inc., the Company entered into a corporate advisory agreement with Aquiva Medical Inc. (”Aquiva Medical”), an innovative healthcare company which operates within the dermatology medical technology sector.
Related news for (HSTA)
- Hestia Insight Inc. Unveils Innovative Marketing Plan to Assist Emerging Companies
- Hestia Insight Inc. Announces Upcoming Launch of AI-Powered IR Website Platform to Assist Start-Ups, Small and Medium Sized Companies
- Hestia Insight Inc. Signs Letter of Intent With Leading Wound Care Company
- Hestia Insight Inc. Signs Letter of Intent With Major Asian-Pacific Health Care Products Distributor